141 related articles for article (PubMed ID: 17172496)
21. Carcinoma of the gastroesophageal junction in Chinese patients.
Huang Q
World J Gastroenterol; 2012 Dec; 18(48):7134-40. PubMed ID: 23326117
[TBL] [Abstract][Full Text] [Related]
22. Time trends and pathological profile of carcinoma lower oesophagus and gastro-oesophageal junction over the last 20 years--an experience from South India.
Tony J; Kumar SK; Thomas V
Trop Gastroenterol; 2007; 28(3):113-6. PubMed ID: 18383999
[TBL] [Abstract][Full Text] [Related]
23. A rising trend of gastric cardia cancer in Gansu Province of China.
Zhou Y; Zhang Z; Zhang Z; Wu J; Ren D; Yan X; Wang Q; Wang Y; Wang H; Zhang J; Zhu X; Yang Y; Luo C; Guo X; Tang C; Qiao L
Cancer Lett; 2008 Sep; 269(1):18-25. PubMed ID: 18501504
[TBL] [Abstract][Full Text] [Related]
24. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
25. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.
Rice TW; Blackstone EH; Rusch VW
Ann Surg Oncol; 2010 Jul; 17(7):1721-4. PubMed ID: 20369299
[No Abstract] [Full Text] [Related]
26. Tumors of the esophagus, gastroesophageal junction, and stomach.
Sweed MR; Edmonson D; Cohen SJ
Semin Oncol Nurs; 2009 Feb; 25(1):61-75. PubMed ID: 19217506
[TBL] [Abstract][Full Text] [Related]
27. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
28. Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System.
Huang Q; Shi J; Feng A; Fan X; Zhang L; Mashimo H; Cohen D; Lauwers G
Mod Pathol; 2011 Jan; 24(1):138-46. PubMed ID: 20852593
[TBL] [Abstract][Full Text] [Related]
29. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
Wei S; Tian J; Song X; Chen Y
Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
[TBL] [Abstract][Full Text] [Related]
30. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
31. Histopathological features of the gastroesophageal junction: an Eastern view.
Kim A; Shin N; Lee HJ; Jo HJ; Kim JY; Kim YK; Park DY; Park WY; I H; Kim GH
Histol Histopathol; 2015 Jun; 30(6):689-95. PubMed ID: 25236753
[TBL] [Abstract][Full Text] [Related]
32. Squamous metaplasia with reserve cell hyperplasia in the esophagogastric junction zone.
Takubo K
Acta Pathol Jpn; 1981 May; 31(3):349-59. PubMed ID: 7270146
[TBL] [Abstract][Full Text] [Related]
33. Controversies of cardiac glands in the proximal stomach: a critical review.
Huang Q
J Gastroenterol Hepatol; 2011 Mar; 26(3):450-5. PubMed ID: 21332541
[TBL] [Abstract][Full Text] [Related]
34. Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.
Strong VE; D'Amico TA; Kleinberg L; Ajani J
J Natl Compr Canc Netw; 2013 Jan; 11(1):60-6. PubMed ID: 23307982
[TBL] [Abstract][Full Text] [Related]
35. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma.
Takubo K; Aida J; Naomoto Y; Sawabe M; Arai T; Shiraishi H; Matsuura M; Ell C; May A; Pech O; Stolte M; Vieth M
Hum Pathol; 2009 Jan; 40(1):65-74. PubMed ID: 18755496
[TBL] [Abstract][Full Text] [Related]
36. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
37. A proposal for a new validated histological definition of the gastroesophageal junction.
Chandrasoma P; Makarewicz K; Wickramasinghe K; Ma Y; Demeester T
Hum Pathol; 2006 Jan; 37(1):40-7. PubMed ID: 16360414
[TBL] [Abstract][Full Text] [Related]
38. SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.
Horton RK; Ahadi M; Gill AJ; Said S; Chen ZE; Bakhshwin A; Nichols M; Goldblum JR; Graham RP
Am J Surg Pathol; 2021 Mar; 45(3):414-420. PubMed ID: 33027072
[TBL] [Abstract][Full Text] [Related]
39. [Endoscopic diagnosis of early cancer in the esophagogastric junctional region].
Takeshita K; Kawano T; Saito N; Nagai K; Tani M; Honda T; Inoue H; Yano K; Hayashi S; Saeki I; Iwai T
Nihon Geka Gakkai Zasshi; 1998 Sep; 99(9):558-63. PubMed ID: 9842540
[TBL] [Abstract][Full Text] [Related]
40. Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.
Li-Chang HH; Kasaian K; Ng Y; Lum A; Kong E; Lim H; Jones SJ; Huntsman DG; Schaeffer DF; Yip S
BMC Cancer; 2015 Feb; 15():32. PubMed ID: 25656989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
